These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36763263)

  • 1. Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.
    Tsai SJ; Kao CF; Su TP; Li CT; Lin WC; Hong CJ; Bai YM; Tu PC; Chen MH
    CNS Drugs; 2023 Mar; 37(3):243-253. PubMed ID: 36763263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low-dose ketamine infusion on vascular endothelial growth factor and matrix metalloproteinase-9 among patients with treatment-resistant depression and suicidal ideation.
    Chen MH; Lin WC; Li CT; Wu HJ; Bai YM; Tsai SJ; Su TP; Tu PC
    J Psychiatr Res; 2023 Sep; 165():91-95. PubMed ID: 37487293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
    Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
    J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study.
    Chen MH; Kao CF; Tsai SJ; Li CT; Lin WC; Hong CJ; Bai YM; Tu PC; Su TP
    Genomics; 2021 Mar; 113(2):507-514. PubMed ID: 33370585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study.
    Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
    Psychiatry Res; 2018 Nov; 269():207-211. PubMed ID: 30153598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review.
    Sukhram SD; Yilmaz G; Gu J
    Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is one or two infusions better in the first week of low-dose ketamine treatment for medication-resistant depression? A post hoc pooled analysis of randomized placebo-controlled and open-label trials.
    Chen MH; Wu HJ; Li CT; Lin WC; Tsai SJ; Hong CJ; Tu PC; Bai YM; Mao WC; Su TP
    J Psychiatr Res; 2021 Dec; 144():448-454. PubMed ID: 34752941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.
    Chen MH; Wu HJ; Li CT; Lin WC; Tsai SJ; Hong CJ; Tu PC; Bai YM; Mao WC; Su TP
    Hum Psychopharmacol; 2022 Mar; 37(2):e2820. PubMed ID: 34597436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression.
    Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
    CNS Spectr; 2021 Aug; 26(4):362-367. PubMed ID: 32419678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study.
    Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
    J Affect Disord; 2018 Jan; 225():709-714. PubMed ID: 28922734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.
    Chen MH; Cheng CM; Gueorguieva R; Lin WC; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Krystal JH; Su TP
    Neuropsychopharmacology; 2019 Nov; 44(12):2112-2118. PubMed ID: 31421635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine.
    Zhou Y; Wang C; Lan X; Li H; Chao Z; Ning Y
    J Neuroinflammation; 2021 Sep; 18(1):200. PubMed ID: 34526064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response: Reexploring the Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression.
    Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
    J Clin Psychiatry; 2020 Nov; 81(6):. PubMed ID: 33176071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using classification and regression tree modelling to investigate treatment response to a single low-dose ketamine infusion: Post hoc pooled analyses of randomized placebo-controlled and open-label trials.
    Chen MH; Wu HJ; Li CT; Lin WC; Bai YM; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
    J Affect Disord; 2021 Feb; 281():865-871. PubMed ID: 33239245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.
    Siegel JS; Palanca BJA; Ances BM; Kharasch ED; Schweiger JA; Yingling MD; Snyder AZ; Nicol GE; Lenze EJ; Farber NB
    Psychopharmacology (Berl); 2021 Apr; 238(4):1157-1169. PubMed ID: 33483802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study.
    Kang MJY; Vazquez GH
    J Affect Disord; 2022 Dec; 318():331-337. PubMed ID: 36070831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose ketamine infusion for treating subjective cognitive, somatic, and affective depression symptoms of treatment-resistant depression.
    Chen MH; Wu HJ; Li CT; Lin WC; Tsai SJ; Hong CJ; Tu PC; Bai YM; Mao WC; Su TP
    Asian J Psychiatr; 2021 Dec; 66():102869. PubMed ID: 34592639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial.
    Beanes G; Caliman-Fontes AT; Souza-Marques B; Silva HDS; Leal GC; Carneiro BA; Guerreiro-Costa LNF; Figueiredo AV; Figueiredo CAV; Lacerda ALT; Costa RDS; Quarantini LC
    Clin Neuropharmacol; 2022 Nov-Dec 01; 45(6):151-156. PubMed ID: 36093918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.
    Kiraly DD; Horn SR; Van Dam NT; Costi S; Schwartz J; Kim-Schulze S; Patel M; Hodes GE; Russo SJ; Merad M; Iosifescu DV; Charney DS; Murrough JW
    Transl Psychiatry; 2017 Mar; 7(3):e1065. PubMed ID: 28323284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Neurofilament Light Chain With the Antidepressant Effects of Low-Dose Ketamine Infusion Among Patients With Treatment-Resistant Depression.
    Lin WC; Su TP; Li CT; Wu HJ; Bai YM; Liu YL; Tu PC; Chen MH
    Int J Neuropsychopharmacol; 2023 Sep; 26(9):649-653. PubMed ID: 37490687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.